Follicular thyroid cancer overview

Revision as of 13:54, 30 October 2019 by Farima Kahe (talk | contribs)
Jump to navigation Jump to search

Follicular thyroid cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Follicular thyroid cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

X-ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Follicular thyroid cancer overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Follicular thyroid cancer overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Follicular thyroid cancer overview

CDC on Follicular thyroid cancer overview

Follicular thyroid cancer overview in the news

Blogs on Follicular thyroid cancer overview

Directions to Hospitals Treating Follicular thyroid cancer

Risk calculators and risk factors for Follicular thyroid cancer overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]

Overview

Thyroid cancer was first described by William Stewart Halsted, an American surgeon in the late nineteenth century. Follicular thyroid cancer may be classified according to WHO classification into 2 subtype including minimally invasive follicular thyroid carcinoma, and widely invasive follicular thyroid carcinoma. Follicular thyroid cancer arises from follicular cells of thyroid, which are secretory cells that are normally involved in production and secretion of thyroid hormones, thyroxine (T4) and triiodothyronine (T3). Genes involved in the pathogenesis of follicular thyroid cancer include Ras, PAX8/PPARγ, and PTEN. Follicular thyroid cancer must be differentiated from other diseases that cause neck masses such as goiter, Grave's disease, Hurthle cell carcinoma, anaplastic thyroid carcinoma, papillary thyroid carcinoma, and medullary thyroid carcinoma. The incidence of follicular thyroid cancer is estimated to be 0.82 per 100 000 person-years. The female to male ratio is approximately 3 to 1. Common risk factors in the development of follicular thyroid cancer are iodine deficiency, family history of thyroid cancer, radiation exposure, and age. MRI may be helpful in the diagnosis of follicular thyroid cancer. MRI may also be performed to detect metastases of follicular thyroid cancer to brain and bones. On biopsy, follicular thyroid cancer is characterized by trabecular, solid, follicular tumor cells that invade tumor capsule or surrounding vascular structures. Surgery is the mainstay of treatment for follicular thyroid cancer.

Historical Perspective

In 1811, the first thyroid cancer case was reported. Thyroid cancer was first described by William Stewart Halsted, an American surgeon in the late nineteenth century.

Classification

Follicular thyroid cancer may be classified according to WHO classification into 2 subtypes including minimally invasive follicular thyroid carcinoma, and widely invasive follicular thyroid carcinoma.

Pathophysiology

Follicular thyroid cancer arises from follicular cells of thyroid, which are secretory cells that are normally involved in production and secretion of thyroid hormones, thyroxine (T4) and triiodothyronine (T3). Genes involved in the pathogenesis of follicular thyroid cancer include RAS, PAX8/PPARγ, and PTEN.

Causes

Follicular thyroid cancer is caused by a mutation in the RAS gene

Differential Diagnosis

Follicular thyroid cancer must be differentiated from other diseases that cause neck masses such as goiter, Grave's disease, Hurthle cell carcinoma, anaplastic thyroid carcinoma, papillary thyroid carcinoma, and medullary thyroid carcinoma.

Epidemiology and Demographics

The incidence of follicular thyroid cancer is estimated to be 0.82 per 100 000 person-years. Females are more commonly affected with follicular thyroid cancer than males. The female to male ratio is approximately 3 to 1. The incidence of follicular thyroid cancer increases with age; the median age at diagnosis is 45 to 50 years.

Risk Factors

Common risk factors in the development of follicular thyroid cancer are iodine deficiency, family history of thyroid cancer, radiation exposure, and age.

Natural history, Complications and Prognosis

Depending on the extent of the tumor at the time of diagnosis, the prognosis of follicular thyroid cancer may vary. However, the prognosis is generally regarded as poor. The presence of metastasis is associated with a particularly poor prognosis among patients with follicular thyroid cancer.

Staging

According to the American Joint Committee on Cancer (AJCC)[1] there are 4 stages of follicular thyroid cancer based on the clinical features and findings on imaging. Each stage is assigned a letter and a number that designate the tumor size, number of involved lymph node regions, and metastasis.

History and Symptoms

The hallmark of follicular thyroid cancer is swelling in the neck. A positive history of irradiation of head and neck, rapid growth of the nodule, hoarseness of voice, and family history of follicular carcinoma is suggestive of follicular thyroid cancer. The most common symptoms of follicular thyroid cancer include swelling in the neck, pain in the front of the neck, and hoarseness of voice.

Physical Examination

Patients with follicular thyroid cancer usually appear thin and cachectic. Physical examination of patients with follicular thyroid cancer is usually remarkable for thyromegaly, lymphadenopathy and anxiety.

Laboratory Findings

Laboratory findings consistent with the diagnosis of follicular thyroid cancer include elevated T3, elevated T4, and decreased thyroid stimulating hormone.

Chest x-ray

Chest x-ray may be helpful in the diagnosis of follicular thyroid cancer.

CT

CT scan may be helpful in the diagnosis of diffuse follicular thyroid cancer.

MRI

MRI may be helpful in the diagnosis of follicular thyroid cancer. MRI may also be performed to detect metastases of follicular thyroid cancer to brain and bones.

Echocardiography or Ultrasound

Neck ultrasound may be performed to detect follicular thyroid cancer.

Other Imaging Findings

Other diagnostic studies for follicular thyroid cancer include radioiodine scan, which demonstrates increased uptake of radioactive iodine at the areas of metastases and laryngoscopy which demonstrates vocal cord immobility.

Biopsy

On biopsy, follicular thyroid cancer is characterized by trabecular, solid, follicular tumor cells that invade tumor capsule or surrounding vascular structures.

Medical Therapy

Patients with follicular thyroid cancer are treated with radioactive iodine therapy and targeted medical therapy.

Surgery

Surgery is the mainstay of treatment for follicular thyroid cancer.

Prevention

Effective measures for the prevention of follicular thyroid cancer include avoidance of diets low in iodine and avoidance of ultraviolet exposure.

Reference

  1. Stage Information for Thyroid Cancer Cancer.gov (2015). http://www.cancer.gov/types/thyroid/hp/thyroid-treatment-pdq#link/stoc_h2_2- cancer staging Accessed on October, 29 2015